Search Results
Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE)
Dr. Tania Kamphaus Presents the NIMBLE Program at the 2021 NASH Summit
Collaboration in action - Foundation for the National Institutes of Health | Roberto Calle
Case Study: Discovery of an early diagnostic biomarker for NASH
Leveraging Clinical Pharmacology to Optimize Drug Development for NASH & Cholestatic Liver Diseases2
NASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes | Arun Sanyal
A Proteomics Signature of NASH
Systematic Review of Syndrome Biomarkers in Metabolic Disorders Insights into Dysfunctions
News on NASH – Selected Highlights from The Liver Meeting 2021
Non-invasiveTestss and Liver Biopsies in MASH - Live Panel Discussion
Conference about NASH disease in New York City - International NASH Day 2019
High Point CTC 2nd Yearly NASH Webinar
